SQZ Biotechnologies Co CEO Armon Sharei's 2020 pay jumps 132% to $2.3M
SQZ Biotechnologies Co reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
SQZ Biotechnologies Co reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, five executives at SQZ Biotechnologies Co received on average a compensation package of $1.5M, a 7% increase compared to previous year.
Average pay of disclosed executives at SQZ Biotechnologies Co
Armon Sharei, Chief Executive Officer, received $2.3M in total, which increased by 132% compared to 2019. 70% of Sharei's compensation, or $1.6M, was in option awards. Sharei also received $218K in non-equity incentive plan, $467K in salary, as well as $7K in other compensation.
Micah Zajic, Chief Business Officer, received a compensation package of $2M. 86% of the compensation package, or $1.7M, was in option awards.
Lawrence Knopf, General Counsel, earned $1.4M in 2020.
Oliver Rosen, Chief Medical Officer, received $1.1M in 2020, which decreases by 26% compared to 2019.
Teri Loxam, Chief Financial Officer, earned $773K in 2020, a 57% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2021.